Canadian Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Sweet Earth Holdings

Market Cap: CA$6.6m

Does not have significant operations.

High Tide

Market Cap: CA$435.6m

Engages in the cannabis retail business in Canada.

Vaxil Bio

Market Cap: CA$520.5k

A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.

Onco-Innovations

Market Cap: CA$97.7m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

Restart Life Sciences

Market Cap: CA$2.5m

Through its subsidiaries, operates as a biotechnology company worldwide.

XORTX Therapeutics

Market Cap: CA$6.4m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

Medicure

Market Cap: CA$11.5m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Entheon Biomedical

Market Cap: CA$1.2m

Operates as a biotechnology research and development company.

Thiogenesis Therapeutics

Market Cap: CA$36.8m

A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

Psyence Group

Market Cap: CA$2.2m

A life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma.

Devonian Health Group

Market Cap: CA$24.6m

Engages in the development of botanical drugs.

Innovotech

Market Cap: CA$9.5m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

BioSyent

Market Cap: CA$130.6m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Cronos Group

Market Cap: CA$1.4b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Medicenna Therapeutics

Market Cap: CA$85.1m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

1CM

Market Cap: CA$45.9m

Operates as a multi-jurisdictional cannabis company in Canada.

Bright Minds Biosciences

Market Cap: CA$492.7m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Steep Hill

Market Cap: CA$970.7k

Does not have significant operations.

Pharmala Biotech Holdings

Market Cap: CA$12.3m

Pharmala Biotech Holdings Inc., doing business as PharmAla, a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

NurExone Biologic

Market Cap: CA$91.5m

A pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.

MediPharm Labs

Market Cap: CA$29.5m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

Covalon Technologies

Market Cap: CA$59.8m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

Organigram Global

Market Cap: CA$334.5m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

ME Therapeutics Holdings

Market Cap: CA$118.4m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Nextleaf Solutions

Market Cap: CA$11.8m

A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.

Atlas Energy

Market Cap: CA$94.4m

A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

Eupraxia Pharmaceuticals

Market Cap: CA$290.2m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Satellos Bioscience

Market Cap: CA$124.2m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

Telescope Innovations

Market Cap: CA$24.6m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

SOL Global Investments

Market Cap: CA$11.5m

A private equity firm specializing in emerging growth.

Aurora Cannabis

Market Cap: CA$391.8m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Crescita Therapeutics

Market Cap: CA$9.0m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

Avant Brands

Market Cap: CA$9.0m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Cipher Pharmaceuticals

Market Cap: CA$412.0m

Operates as a specialty pharmaceutical company in Canada.

Lobe Sciences

Market Cap: CA$13.2m

A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.

Vireo Growth

Market Cap: CA$683.9m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.